Appeals court sides with Trump in fight over subpoena of gender-affirming care provider
LGBTQ

Appeals court sides with Trump in fight over subpoena of gender-affirming care provider

Aug 15, 2026Updated 12:30pm ET

The 9th U.S. Circuit Court of Appeals revived a Justice Department subpoena seeking QueerDoc’s personnel, billing, and patient records in a dispute over whether the Trump administration is using federal investigations to target gender-affirming care for minors.

The 9th U.S. Circuit Court of Appeals revived a Justice Department subpoena seeking QueerDoc’s personnel, billing, and patient records in a dispute over whether the Trump administration is using federal investigations to target gender-affirming care for minors.

Corroboration

LowMedHigh
ReutersPOLITICOABC News MediaBloombergClickOnDetroitDetroit Local News

Confirmed by 13+ sources.

What This is

  • The 9th U.S. Circuit Court of Appeals ruled 2-1 to revive a Justice Department subpoena seeking records from telemedicine provider QueerDoc.
  • The subpoena seeks personnel, billing, and patient records from QueerDoc, which provides gender-affirming care to minors.
  • The appeals court said a president’s policy goal of ending gender-affirming care is not, by itself, an improper reason to direct Justice Department enforcement.
  • The subpoena fight is part of a wider Trump administration effort, including an executive order, to curb federal support and increase scrutiny of gender-affirming care for minors.
  • The Trump administration has asked DOJ and the HHS inspector general to review billing and coding for pediatric gender-affirming care at more than 200 hospitals, clinics, and pharmacy providers.

Why This Matters

  • It tests how much a president can steer federal investigations toward a contested health policy goal.
  • It raises privacy and consent concerns when law enforcement seeks sensitive youth medical records.
  • It could change how willing hospitals, insurers, and telehealth providers are to offer or cover gender-affirming care if billing choices may trigger fraud probes.
  • It shapes trust in whether federal “fraud” actions are about patient protection or political pressure.

Who else would want to know this?